-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCRYST ANNOUNCES FDA APPROVAL OF ORLADEYO® (BEROTRALSTAT) ORAL PELLETS, FIRST AND ONLY ORAL PROPHYLACTIC TREATMENT FOR PATIENTS WITH HAE AGED 2 TO <12 YEARS

Reuters·12/12/2025 12:00:00

Please log in to view news